C. Takemoto

发表

Pediatric Hospital Acquired Venous Thromboembolism

C. Witmer, C. Takemoto, 2017, Front. Pediatr..

Challenges in the management of the transgender patient with sickle cell disease

C. Takemoto, R. Naik, S. Lanzkron, 2018, American journal of hematology.

Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines

J. Allanson, B. Gelb, A. Roberts, 2010, Pediatrics.

Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease

J. Keefer, G. Kato, J. Strouse, 2008, Pediatric blood & cancer.

Thrombotic disease in critically ill children

J. Tobias, C. Takemoto, K. Brady, 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.

M. Streiff, C. Takemoto, P. Kraus, 2013, American journal of clinical pathology.

increased neutrophil CXCR4 expression and myelokathexis Severe congenital neutropenia resulting from G6PC3 deficiency with

S. Paul, D. Kuhns, J. Chou, 2011 .

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.

S. Paul, D. Kuhns, D. McDermott, 2010, Blood.

Venous thromboembolism in cystic fibrosis

C. Takemoto, 2012, Pediatric pulmonology.

Prognostic risk‐stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012

R. Goel, A. Tobian, C. Takemoto, 2016, Transfusion.

Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

R. Goel, A. Tobian, L. Krishnamurti, 2015, Blood.

Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities.

N. Goldenberg, C. Takemoto, J. Kittelson, 2015, Blood.

The p85α Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration

A. Robling, C. Takemoto, Sasidhar Vemula, 2008, Molecular and Cellular Biology.

Approach to pancytopenia: Diagnostic algorithm for clinical hematologists.

C. Francis, C. Takemoto, S. Hashmi, 2018, Blood reviews.

Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin‐2 levels

E. Boscolo, D. Adams, T. L. Le Cras, 2020, Pediatric blood & cancer.

Von Willebrand disease.

C. Takemoto, S. Cooper, 2014, Pediatrics in review.

SHP-1 Deficient Mast Cells Are Hyperresponsive to Stimulation and Critical in Initiating Allergic Inflammation in the Lung

J. Schroeder, C. Takemoto, Zhou Zhu, 2009, The Journal of Immunology.

SHP-1 Regulation of Mast Cell Function in Allergic Inflammation and Anaphylaxis

N. Van Rooijen, C. Takemoto, Zhou Zhu, 2013, PloS one.

Mast cells--friend or foe?

C. Takemoto, 2010, Journal of pediatric hematology/oncology.

Coagulation Disorders in Congenital Heart Disease

C. Takemoto, C. Ozment, K. N. McMillan, 2019, Critical Heart Disease in Infants and Children.

Global microRNA expression is essential for murine mast cell development in vivo.

C. Takemoto, R. Kapur, Zhou Zhu, 2014, Experimental hematology.

Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit.

E. Amankwah, M. Streiff, N. Goldenberg, 2014, Thrombosis research.

Incorporating G6PD genotyping to identify patients with G6PD deficiency

M. Relling, U. Broeckel, Wenjian Yang, 2021, Pharmacogenetics and genomics.

PLATELETS AND THROMBOPOIESIS Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality

R. Goel, A. Tobian, L. Krishnamurti, 2015 .

Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.

Sybil A. Klaus, M. Streiff, S. Klaus, 2014, The Journal of pediatrics.

Heparin-induced thrombocytopenia screening and management in pediatric patients.

M. Streiff, C. Takemoto, 2011, Hematology. American Society of Hematology. Education Program.

The p85 (cid:2) Subunit of Class I A Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration (cid:1)

A. Robling, C. Takemoto, Sasidhar Vemula, 2008 .

Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score*

Richard E Thompson, F. D. Stewart, E. Haut, 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Expression in Mast Cells PU.1 Positively Regulates GATA-1

A. Jegga, C. Takemoto, R. DeKoter, 2010 .

Rituximab for ITP: A long‐term fix?

C. Takemoto, 2009, Pediatric blood & cancer.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia

Allen R. Chen, Richard J. Jones, R. Brodsky, 2016, Journal of pediatric hematology/oncology.

Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.

R. Tamargo, Judy Huang, E. Ahn, 2017, Journal of neurosurgery. Pediatrics.

A Versatile and Efﬁcient Novel Approach for Mendelian Randomization Analysis with Application to Assess the Causal Effect of Fetal Hemoglobin on Anemia in Sickle Cell Anemia

Yuehua Cui, S. Burgess, V. Sheehan, 2022 .

The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor.

G. Krystal, H. Martin, R. Chan, 2011, Blood.

microphthalmia transcription factor The PI3K pathway drives the maturation of mast cells via

G. Krystal, H. Martin, R. Chan, 2011 .

D‐dimer for the diagnosis of venous thromboembolism in children

P. Tamma, J. Strouse, C. Takemoto, 2009, American journal of hematology.

PU.1 Positively Regulates GATA-1 Expression in Mast Cells

A. Jegga, M. McDevitt, C. Takemoto, 2010, The Journal of Immunology.

Retrospective cohort study comparing activated partial thromboplastin time versus anti‐factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics

Christoph U. Lehmann, M. Streiff, C. Takemoto, 2015, Journal of thrombosis and haemostasis : JTH.

Balanced Interactions between Lyn, the p85α Regulatory Subunit of Class IA Phosphatidylinositol-3-Kinase, and SHIP Are Essential for Mast Cell Growth and Maturation

E. Hashino, C. Takemoto, Baskar Ramdas, 2011, Molecular and Cellular Biology.

Primary Antiphospholipid Antibody Syndrome and Cardiac Involvement in a Child

M. Manco‐Johnson, C. Takemoto, P. Spevak, 2003, Pediatric Cardiology.

F, Spiro I: Posttransplantation lymphoproliferative disorders in solid Nephrotic Syndrome as a Complication of Immune Tolerance in Hemophilia B

I. Warrier, P. Saidi, J. Lusher, 1997 .

Correlates of successful transition in young adults with sickle cell disease

J. Strouse, C. Takemoto, J. Casella, 2019, Pediatric blood & cancer.

Current and future treatment approaches for Barth syndrome

W. Pu, Reid Thompson, M. Chin, 2021, Journal of inherited metabolic disease.

First report on the safety and efficacy of an extended half‐life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A

E. Santagostino, A. Neff, C. Négrier, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis

K. Hong, M. Streiff, K. Desai, 2012, British journal of haematology.

Catheter-Directed Thrombolysis of Inferior Vena Cava Thrombosis in a 13-Day-Old Neonate and Review of Literature

M. Streiff, C. Takemoto, J. Casella, 2008, Cardiovascular and Interventional Radiology.

Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B

S. Rosen, B. Ewenstein, C. Takemoto, 1998, Pediatric Nephrology.

First Report on the Safety and Efficacy of a Long-Acting Recombinant FVIII (turoctocog alfa pegol, N8-GP) during Major Surgery in Patients with Severe Hemophilia a

E. Santagostino, A. Neff, C. Négrier, 2015 .

Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure

C. Takemoto, W. Savage, T. Kickler, 2007, Pediatric blood & cancer.

Hemostasis/Thrombosis Considerations in Vascular Anomalies

L. Brandão, C. Takemoto, 2020 .

c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi.

E. Price, D. Fisher, M. Horstmann, 2000, Genes & development.

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes

E. Price, D. Fisher, C. Takemoto, 1998, Nature.

How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C

A. Sharathkumar, C. Takemoto, E. V. Faustino, 2021, Pediatric blood & cancer.

Platelet transfusion practices in immune thrombocytopenia related hospitalizations

J. Bussel, S. Kaicker, L. Vasovic, 2018, Transfusion.

Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.

D. Fisher, C. Hershey, C. Takemoto, 2001, Molecular cell.

Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3

D. Fisher, C. Hershey, M. Horstmann, 1998, The Journal of experimental medicine.

Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance.

D. Fisher, Y. Nobukuni, I. Kobayashi, 2000, Human molecular genetics.

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia.

C Conover Talbot, Jeanne Kowalski, Alan H Beggs, 2008, Blood.

Mast cell transcriptional networks.

A. Jegga, M. McDevitt, Y. Ye, 2008, Blood cells, molecules & diseases.

Juvenile Idiopathic Arthritis Associated with Combined JP–HHT Syndrome: A Novel Phenotype Associated with a Novel Variant in SMAD4

S. Mitchell, J. Collaco, J. Bodurtha, 2017, Journal of Pediatric Genetics.

The Identification and Functional Characterization of a Novel Mast Cell Isoform of the Microphthalmia-associated Transcription Factor*

D. Fisher, C. Takemoto, Yori Yoon, 2002, The Journal of Biological Chemistry.

The Genomic Landscape of Juvenile Myelomonocytic Leukemia

T. Golub, M. Loh, G. Getz, 2015, Nature Genetics.

Genetic Evidence for Critical Roles of P38α Protein in Regulating Mast Cell Differentiation and Chemotaxis through Distinct Mechanisms*

A. Nebreda, N. Carlesso, P. Hu, 2012, The Journal of Biological Chemistry.

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Michael A McDevitt, Pierre Noel, E. Wentzel, 2011, Blood.

Reduced intensity chemotherapy with tyrosine kinase inhibitor and blinatumomab in a pediatric patient with Philadelphia chromosome‐positive ALL and mechanical heart valves

C. Pui, C. Takemoto, H. Inaba, 2021, Pediatric blood & cancer.

Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death.

P. Hahnfeldt, L. Hlatky, D. Fisher, 1999, International journal of radiation oncology, biology, physics.

Distinct and Shared Transcriptomes Are Regulated by Microphthalmia-Associated Transcription Factor Isoforms in Mast Cells1

C. Jie, C. Takemoto, A. Shahlaee, 2007, The Journal of Immunology.

Diagnostic utility of telomere length testing in a hospital-based setting

Margaret A. Strong, Ludmila V. Danilova, S. E. Stanley, 2018, Proceedings of the National Academy of Sciences.

Computerized Physician Order Entry Improves Compliance With a Manual Exchange Transfusion Protocol in the Pediatric Intensive Care Unit

J. Strouse, C. Takemoto, R. Easley, 2014, Journal of pediatric hematology/oncology.

Diagnostic utility of telomere length measurement in a hospital setting

Margaret A. Strong, Ludmila V. Danilova, S. E. Stanley, 2017, bioRxiv.

Lymphadenopathy as the primary manifestation of malignant transformation in two patients with severe congenital neutropenia

M. Borowitz, M. Horwitz, J. Strouse, 2008, Pediatric blood & cancer.

The Molecular Basis of Blood Diseases, 3rd edition.

C. Takemoto, 2002 .

Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

S. Janga, B. Vanhaesebroeck, S. Paczesny, 2018, JCI insight.

Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

Neil A Goldenberg, E. Amankwah, M. Streiff, 2014, The Journal of pediatrics.

Iron Status is Associated with Asthma and Lung Function in US Women

Elizabeth C. Matsui, M. McCormack, E. Matsui, 2015, PloS one.

Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry

S. Sheth, L. Vasovic, R. Goel, 2018, JAMA surgery.

Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.

M. Gladwin, B. Pace, A. Raj, 2021, JAMA.

Diagnosis of congenital and acquired focal lesions in the neck, abdomen, and pelvis with contrast-enhanced ultrasound: a pictorial essay

T. Huisman, J. Gearhart, C. Takemoto, 2018, European Journal of Pediatrics.

Correction: Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia

T. Golub, M. Loh, G. Getz, 2016, Nature Genetics.

development of a new risk model for hospital-associated venous thromboembolism (ha-vte) in the pediatric intensive care unit (picu): findings from a large single-institutional case-control study : Pht02

E. Amankwah, M. Streiff, N. Goldenberg, 2014 .

A novel diagnostic algorithm for heparin‐induced thrombocytopenia

M. Streiff, C. Takemoto, K. Salimian, 2018, International journal of laboratory hematology.

The Clinical Utility of the Heparin Neutralization Assay in the Diagnosis of Heparin-Induced Thrombocytopenia

D. Judge, M. Streiff, Elise Gelwan, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States

R. Goel, S. Frank, Eshan U. Patel, 2018, Transfusion.

Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries.

M. Relling, Cheng Cheng, C. Pui, 2023, Haematologica.

Risk factors for hospital-associated venous thromboembolism in critically ill children following cardiothoracic surgery or therapeutic cardiac catheterisation

M. Jacobs, E. Amankwah, A. Everett, 2017, Cardiology in the Young.

Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery.

E. Amankwah, M. Streiff, N. Goldenberg, 2015, Thrombosis research.

Kit Signaling Regulates Mitf Expression in Mastocytosis.

D. Metcalfe, C. Takemoto, R. Kapur, 2006 .

Venous thromboembolism in cystic fibrosis

C. Takemoto, 2012, Pediatric pulmonology.

Sickle cell disease: Matters of the heart

C. Takemoto, 2005, Pediatric blood & cancer.

Immune thrombocytopenia due to Trimethoprim‐Sulfamethoxazole; under‐recognized adverse drug reaction in children?

Michael A. Veltri, J. Strouse, C. Takemoto, 2015, Pediatric blood & cancer.